Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Retained Earnings: 2018-2021

  • Genmab A's Retained Earnings fell 3.77% to $9.74 in Q2 2021 from the same period last year, while for Jun 2021 it was $9.74, marking a year-over-year decrease of 3.77%. This contributed to the annual value of $6.3 million for FY2020, which is 38.45% down from last year.
  • Genmab A's Retained Earnings amounted to $9.74 in Q2 2021, which was down 100.00% from $6.3 million recorded in Q4 2020.
  • Genmab A's 5-year Retained Earnings high stood at $10.2 million for Q4 2019, and its period low was $9.74 during Q2 2021.
  • For the 3-year period, Genmab A's Retained Earnings averaged around $5.3 million, with its median value being $6.3 million (2020).
  • Its Retained Earnings has fluctuated over the past 5 years, first climbed by 0.51% in 2019, then tumbled by 100.00% in 2020.
  • Genmab A's Retained Earnings (Quarterly) stood at $10.1 million in 2018, then climbed by 0.51% to $10.2 million in 2019, then tumbled by 38.45% to $6.3 million in 2020, then fell by 3.77% to $9.74 in 2021.
  • Its last three reported values are $9.74 in Q2 2021, $6.3 million for Q4 2020, and $10.12 during Q2 2020.